Kdl Medical
KDL Medical, also known as KDL International, is a prominent player in the medical device industry, headquartered in China. Founded in 2005, the company has established a strong presence in key operational regions across Asia and beyond, focusing on innovative healthcare solutions. Specialising in the development and manufacturing of high-quality medical devices, KDL Medical offers a diverse range of products, including surgical instruments and diagnostic equipment. Their commitment to precision and reliability sets them apart in a competitive market. With a reputation for excellence, KDL Medical has achieved significant milestones, including certifications that underscore their dedication to quality and safety. As a trusted partner in healthcare, KDL Medical continues to enhance patient outcomes through cutting-edge technology and superior service.
DitchCarbon Score
How does Kdl Medical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Kdl Medical's score of 20 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Kdl Medical's reported carbon emissions
Kdl Medical's carbon emissions data reveals significant figures from recent years. In 2019, the company reported total emissions of approximately 14,870,000,000 kg CO2e across all scopes, with Scope 1 emissions at about 187,829,000 kg CO2e, Scope 2 at approximately 1,188,286,000 kg CO2e, and Scope 3 emissions reaching about 14,870,000,000 kg CO2e. The Scope 3 emissions are particularly notable, comprising the majority of their total emissions, driven by the use of sold products, which alone accounted for about 9,570,000,000 kg CO2e. In 2021, Kdl Medical's emissions were significantly lower, with Scope 1 at approximately 41,000 kg CO2e and Scope 2 at about 6,212,000 kg CO2e, totalling around 6,252,000 kg CO2e for Scope 1 and 2 combined. This indicates a substantial reduction in emissions compared to previous years, particularly in Scope 1 and 2. Despite these reductions, Kdl Medical has not publicly committed to specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or climate pledges. The company continues to monitor its emissions, focusing on improving its operational efficiency and reducing its carbon footprint in line with industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2017 | 2018 | 2019 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Scope 1 | 234,291,000 | 000,000,000 | 000,000,000 | 00,000 | 00,000 |
| Scope 2 | 1,156,316,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 16,923,000,000 | 00,000,000,000 | 00,000,000,000 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Kdl Medical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
